ALS-focused QurAlis raises $5.5M in seed money, wins Pfizer ticket to LabCentral

Posted on: Nov 19, 2018   |   Posted by: Biotech Mag

Neurodegenerative disease startup QurAlis has extended the seed round it first announced in April, bringing its total funding up to $5.5 million.